Clinical Trial Results
Discover the data behind NADEssence™. Our commitment to transparency ensures you have access to the rigorous testing and proven efficacy of our NAD+ formulations.
Observed within the first 5 days of daily supplementation.
Across randomized, double-blind, placebo-controlled clinical study.
Favorably impacted over 85 biomarkers and 65 metabolic pathways.
Clinically Relevant Outcomes with Use
Our study focused on intracellular increases in NAD+. There were 52 predefined clinical lab tests with 3,000 proteins and 1,500 metabolites observed. There were no statistically significant adverse findings indicating an excellent safety profile.
- check 52% Increase in treatment group versus placebo (4.5%).
- check Increased sirtuin 1 (SIRT1) activity.
- check Confirmed intracellular uptake in cellular mitochondria.
Liver, Kidney & Oxidative Stress
Results also supported an assocication between supplementation with NADEssence and improved liver and kidney functioning (decreased bilirubin, ALP, serum albumin and GGT) when compared to placebo. GGT, is also a marker of oxidative stress; reductions in GGT may indicate reduced oxidative stress.
“NADEssence stands out because it’s built on mechanism, not marketing. The science, clinical intent, and manufacturing standards align with what healthcare professionals expect from a truly professional-grade product.”
Clinical FAQ
How was the Renewal Study conducted? expand_more
Why you can rely on our measured results? expand_more
Is NADEssence FDA approved? expand_more
What is LathMize™ NAD+? expand_more
Where can I find more information? expand_more
Ready to ignite your cellular spark?
Join thousands of others experiencing the science-backed benefits of optimized NAD+ levels.